{"id":"NCT03664739","sponsor":"Bausch Health Americas, Inc.","briefTitle":"Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris","officialTitle":"A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2 Arm, Parallel Group Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-12-05","primaryCompletion":"2020-03-23","completion":"2020-03-23","firstPosted":"2018-09-10","resultsPosted":"2023-03-29","lastUpdate":"2023-03-29"},"enrollment":608,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Acne Vulgaris"],"interventions":[{"type":"DRUG","name":"IDP-120 Gel","otherNames":[]},{"type":"DRUG","name":"IDp-120 Vehicle Gel","otherNames":[]}],"arms":[{"label":"IDP-120 Gel","type":"EXPERIMENTAL"},{"label":"IDP-120 Vehicle Gel","type":"PLACEBO_COMPARATOR"}],"summary":"study designed to assess the safety, tolerability, and efficacy of IDP-120 Gel and IDP-120 Vehicle Gel","primaryOutcome":{"measure":"Absolute Change in Mean Lesion Counts at Week 12","timeFrame":"Baseline to Week 12","effectByArm":[{"arm":"IDP-120 Gel","deltaMin":-18.5,"sd":10.79},{"arm":"IDP-120 Vehicle Gel","deltaMin":-13.3,"sd":9.68}],"pValues":[]},"eligibility":{"minAge":"9 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":30,"countries":["United States","Canada"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":305},"commonTop":["Application site pain"]}}